TrialThe New England journal of medicine2018
Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Jennifer A Woyach et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
474 papers cite itlatest 60 shown
this paperpooled ittrialcites it